$RLMD Investors have plenty to digest before the next major economic data point.
For biotech, the calendar, trial design, and funding runway deserve close attention. I'm tracking liquidity, cash runway, and the next company update before drawing conclusions.
$RUN Volatility can create opportunity, but the business case must hold. Power demand and data-center electricity needs remain important themes.
One to monitor; the thesis still needs evidence.